DIARRHEA –

1. Introduction

• Diarrhea = increase in frequency + fluidity of stool
• Normal stool: ~200 g/day
• Diarrhea:

o   250 g/day

• 70–95% water
• Frequency: 5–20 times/day
• Severe cases: >1.4 L fluid loss/day
• Main risk: Dehydration → morbidity & mortality

Dysentery

• Low-volume, painful, bloody diarrhea

2. Causes of Diarrhea

Infectious Causes

• Bacteria: Shigella, Salmonella, Vibrio, Campylobacter, Staphylococcus, Escherichia coli
• Viruses: Norovirus, Rotavirus
• Protozoa: Entamoeba histolytica

Non-Infectious Causes

• Contaminated food/water
• Poor hygiene, travel history
• Immunocompromised state
• Drugs:
• Antibiotics
• Magnesium antacids
• NSAIDs
• Prostaglandins
• Diseases:
• IBS
• Hyperthyroidism
• Diabetic neuropathy
• Carcinoid syndrome
• Surgical causes: Reduced gut length

3. WHO Classification

• Acute diarrhea: < 14 days
• Chronic diarrhea: > 14 days

4. Pathophysiology

Diarrhea occurs due to imbalance between absorption & secretion of fluids/electrolytes.

Mechanisms

• ↓ Sodium absorption / ↑ Chloride secretion
• Altered intestinal motility
• ↑ Luminal osmolarity
• ↑ Hydrostatic pressure
• Malabsorption

5. Types of Diarrhea

1. Secretory Diarrhea

• Cause: Toxins, hormones (VIP, serotonin, prostaglandins)
• Features:
• Stool > 500 mL/day
• Continues even during fasting

2. Osmotic Diarrhea

• Cause: Poorly absorbed substances (e.g., lactose intolerance, Mg antacids)
• Features:
• Stops with fasting
• High osmolarity stool

3. Exudative Diarrhea

• Cause: Inflammation (e.g., infections, IBD)
• Features:
• Blood, mucus, pus in stool
• Persistent even during fasting

4. Malabsorption Diarrhea

• Cause: Nutrient absorption defects
• Features:
• Bulky, fatty stool (steatorrhea)
• Improves with fasting

6. Management

A. Non-Pharmacological

• Fluid & electrolyte replacement is key
• ORS (Oral Rehydration Solution) – WHO recommended

Home ORS Formula

• 200 mL boiled & cooled water

·       

• 1 teaspoon sugar

·       

• pinch of salt

Diet Advice

• Bland diet
• Avoid:
• Dairy (initially)
• Solid/heavy foods (first 24 hrs)

B. Pharmacological Management

1. Anti-Motility Drugs

• Reduce intestinal motility → ↑ absorption

Examples:

• Loperamide
• Initial: 4 mg, then 2 mg after each loose stool
• Max: 16 mg/day
• Diphenoxylate
• 5 mg QID (max 20 mg/day)
• Opioids (Tincture opium)
• Risk: Addiction

2. Adsorbents

• Bind toxins & reduce symptoms

Example:

• Kaolin-pectin
• Dose: 30–120 mL after each stool

⚠️ Reduce absorption of other drugs

3. Anti-Secretory Agents

Bismuth Subsalicylate

• Used in traveler’s diarrhea
• Adverse effects:
• Black tongue/stool
• Tinnitus
• Encephalopathy (high dose)

Probiotics

• Restore gut flora

Examples:

• Lactobacillus acidophilus
• Lactobacillus bulgaricus

Dose:

• 2 tablets or 1 sachet 3–4 times/day

Octreotide

• Somatostatin analog
• Used in:
• Carcinoid syndrome
• VIP tumors

Dose: 100–600 mcg/day (SC)

Adverse effects:

• Nausea
• Abdominal pain
• Gallstones

4. Antibacterial Agents

Used in infectious/bloody diarrhea

Examples

• Metronidazole / Tinidazole (amoebiasis)
• Fluoroquinolones:
• Norfloxacin 400 mg
• Ciprofloxacin 500 mg
• Ofloxacin 200 mg

✔ Sometimes used in combination

7. Key Exam Points

• ORS = first-line treatment
• Avoid anti-motility drugs in bloody diarrhea
• Dehydration is the main complication
• Fasting helps differentiate:
• Osmotic (improves)
• Secretory (persists)

Data management and it's components

DATA MANAGEMENT & ITS COMPONENTS

1. Clinical Data Management (CDM)

Clinical Data Management involves:

• Collection, integration, and validation of clinical trial data
• Ensuring data is accurate, reliable, and statistically analyzable

Process Overview

• Investigators collect patient health data over a defined period
• Data is recorded in Case Report Forms (CRFs)
• Data is sent to the sponsor
• Sponsor performs statistical analysis on pooled data
• Data is stored in a Clinical Data Management System (CDMS)

2. Case Report Form (CRF)

• A CRF is a paper or electronic tool used to collect trial data for each subject
• It ensures standardized and consistent data collection across all sites

Functions of CRF

• Ensures accurate and efficient data recording
• Facilitates data processing, analysis, and reporting

STEPS IN DATA MANAGEMENT PROCESS

1. Data Design
2. Data Collection
3. Data Entry
4. Data Validation
5. Data Cleanup
6. Data Analysis
7. Data Reporting
8. Publication

SEQUENTIAL STEPS IN DATA MANAGEMENT

1. Data Design

• Database should allow:
• Accurate data storage
• Easy reporting and interpretation

Types of Databases

• Study Management Database
• Patient details, recruitment, follow-up tracking
• Clinical Database
• Clinical outcomes and study results

Key Functionalities

• Validation rules (range checks, skip logic, consistency checks)
• Query generation and reporting
• Audit trail

2. Data Collection

Key Principles

• Ensure validity and accuracy of data
• Source data must be correctly transcribed
• Regular monitoring (Source Data Verification - SDV)

Before Data Collection

Testing (Pilot Study)

• Test the system before use
• Maintain proper documentation

SOP (Standard Operating Procedures)

• Define:
• Data collection process
• System setup
• Roles and responsibilities

Privacy Risk Assessment

Includes:

• Personal data collected (e.g., Name, DOB)
• Access control
• Data storage and sharing procedures
• Data anonymization
• Risk of confidentiality breaches and mitigation

Training

• Train all users after system validation
• Maintain training records
• Provide workflow diagrams and instructions

During Data Collection

Audit Trail

• Maintain record of all data changes
• Ensure original entries remain traceable

Data Safety

• Protect against:
• Data loss
• Unauthorized access
• Ensure compliance with Good Clinical Practice (GCP)

3. Data Entry

Types

• Manual
• Optical Mark Recognition (OMR)
• Electronic (online/offline)

Important Points

• SOPs must define:
• Who enters data
• How data is entered
• Procedures must be tested and documented
• Staff must be trained
• Quality control checks are essential

Electronic Data Entry

• Data entered directly into electronic CRF (eCRF)
• Can be uploaded via internet/server
• Built-in validation rules prevent incorrect entries

4. Data Validation

Validation Checks

• Range checks
• Skip logic
• Missing data
• Inconsistencies

Output File Checks

• Correct variable names
• Proper coding of categories
• Data format accuracy (e.g., numeric vs text)
• Accurate export to formats like CSV/SPSS

5. Data Cleanup

• Identify:
• Errors
• Missing values
• Inconsistencies
• Corrections must:
• Be justified
• Maintain audit trail
• Queries should be documented

6. Data Analysis

• Conducted by trained statisticians
• Guided by Statistical Analysis Plan (SAP)

SAP Includes

• Primary and secondary outcomes
• Handling missing data
• Statistical methods
• Reporting format

Statistical Methods

• Hierarchical models
• Bayesian analysis
• Decision analysis
• Sequential analysis
• Meta-analysis
• Risk-based allocation

7. Data Reporting

Reports Include

• Recruitment progress
• Follow-up rates
• Data completeness
• Adverse event reconciliation (SAE)
• Withdrawals

8. Database Lock

• Final step before analysis
• Prevents any further data changes

Checklist Includes

• All queries resolved
• Data forms completed
• Coding finalized
• SAE reconciliation completed

9. Data Presentation

• Data presented using:
• Tables
• Graphs
• Statistical summaries

OBJECTIVES OF DATA MANAGEMENT

• Ensure data integrity and quality
• Maintain accuracy and completeness
• Enable valid statistical analysis
• Provide true representation of study results

Nausea and Vomiting

 

RESPONDING TO SYMPTOMS OF MINOR AILMENTS

2) NAUSEA & VOMITING

INTRODUCTION

·        Nausea and vomiting are common complaints, especially in:

• Gastrointestinal disorders
• Chronic diseases (e.g., cancer)

·        Nausea:

• Subjective, unpleasant sensation with an urge to vomit
• Associated with:
• Pallor
• Sweating
• Tachycardia
• Salivation
• Increased respiratory rate

·        Vomiting (Emesis):

• Reflex expulsion of stomach contents through the mouth

·        Retching:

• Involuntary, unsuccessful attempt to vomit

ETIOLOGY (CAUSES)

Common Causes

• Food allergies
• Gastrointestinal infections (e.g., food poisoning, viral gastroenteritis)
• Gastroesophageal reflux disease (GERD)
• Drugs (chemotherapy, radiation therapy)
• Migraine
• Pregnancy (morning sickness)
• Motion sickness
• Severe pain (e.g., kidney stones)
• Excess cannabis use

Serious Causes (Red Flags)

• Appendicitis
• Intestinal obstruction
• Tumors/cancer
• Poisoning or drug ingestion (especially in children)
• Peptic ulcers

CLINICAL PRESENTATION

• Dehydration
• Weight loss
• Mental confusion
• Reduced skin turgor
• Increased thirst
• Hypotension
• Muscle weakness
• Cardiac rhythm disturbances
• Metabolic alkalosis

PATHOPHYSIOLOGY

Phases of Emesis

1. Nausea – urge to vomit
2. Retching – muscular movements without expulsion
3. Vomiting – forceful expulsion of gastric contents

Mechanism

·        Controlled by the vomiting center in the brain

·        Inputs via:

• Vagus nerve
• Splanchnic nerves

·        Stimuli:

• Smell, sight
• Drugs, toxins
• Motion

·        Activation of Chemoreceptor Trigger Zone (CTZ) → initiates vomiting reflex

Key Neurotransmitters Involved

• Dopamine (D₂)
• Histamine (H₁)
• Serotonin (5-HT₃)
• Acetylcholine (Muscarinic)
• Substance P (NK₁ receptors)

PROCESS OF VOMITING

1. Deep inspiration
2. Contraction of abdominal muscles → ↑ intra-abdominal pressure
3. Closure of epiglottis (prevents aspiration)
4. Relaxation of esophagus & pyloric sphincter
5. Expulsion of gastric contents

MANAGEMENT

1) Non-Pharmacological Management

• Avoid triggering foods
• Eat small, frequent meals
• Maintain hydration
• Rest and fresh air
• Behavioral techniques (limited evidence)

2) Pharmacological Management

a) Antacids & Antisecretory Agents

• Neutralize gastric acid
• Example:
• Aluminum hydroxide
• Magnesium hydroxide

b) H₂-Receptor Antagonists

• Reduce acid secretion
• Examples:
• Cimetidine
• Famotidine
• Ranitidine
• Nizatidine

c) Proton Pump Inhibitors (PPIs)

• Strong acid suppression
• Examples:
• Omeprazole
• Esomeprazole
• Pantoprazole
• Rabeprazole
• Lansoprazole

d) Anticholinergics

• Block muscarinic receptors (vestibular system)
• Used in motion sickness
• Example:
• Scopolamine

e) Antihistamines (H₁ blockers)

• Useful in motion sickness, vertigo
• Side effects: sedation, blurred vision
• Examples:
• Diphenhydramine
• Meclizine

f) Dopamine Antagonists (D₂ blockers)

• Act on CTZ
• Side effects: sedation, hypotension, extrapyramidal symptoms
• Examples:
• Metoclopramide
• Domperidone
• Chlorpromazine
• Promethazine

g) Serotonin (5-HT₃) Antagonists

• Block serotonin receptors in CTZ & GI tract
• Used in chemotherapy-induced vomiting
• Example:
• Ondansetron

WHEN TO REFER TO DOCTOR

Immediate referral is needed if:

• Vomiting > 24 hours
• Blood in vomit
• Severe abdominal pain
• Severe headache or stiff neck
• Signs of dehydration:
• Dry mouth
• Reduced urination
• Dark urine
• Suspected poisoning

 

 

Dyspepsia

 

RESPONDING TO SYMPTOMS OF MINOR AILMENTS

3) DYSPEPSIA

INTRODUCTION

• The term dyspepsia is derived from the Greek word meaning “improper digestion.”
• It refers to upper abdominal discomfort usually related to:
• Food intake
• Alcohol consumption
• Common causes include:
• Certain drugs: NSAIDs, antibiotics, digoxin, bisphosphonates, theophylline
• Smoking
• Stressful lifestyle

TYPES

1. Acute (Infrequent) Dyspepsia

• Usually self-limiting
• Associated with:
• Irregular eating habits
• Alcohol intake
• Smoking
• Stress

2. Chronic Dyspepsia

• Recurrent symptoms such as:
• Epigastric pain
• Bloating
• Belching
• Nausea, vomiting
• Early satiety

CAUSES OF DYSPEPSIA

• Peptic ulcer disease
• Gastroesophageal reflux disease (GERD)
• Helicobacter pylori infection
• Gastric malignancy
• Functional (idiopathic) dyspepsia

Functional dyspepsia = No structural abnormality but persistent symptoms

PATHOPHYSIOLOGY

• Visceral hypersensitivity
• Impaired gastric accommodation
• Delayed gastric emptying
• Antral overdistension
• Abnormal gastroduodenal motility

CLINICAL FEATURES

Common Symptoms

• Epigastric discomfort
• Bloating
• Nausea
• Belching
• Early satiety

Alarm Symptoms (Require Endoscopy)

• Unexplained weight loss (>10%)
• Persistent vomiting
• Severe continuous pain
• Dysphagia
• Hematemesis or melena
• Anemia
• Jaundice

INVESTIGATION

·        Patients <55 years without alarm symptoms:

• Test for H. pylori (urea breath test)

·        Patients >35–55 years or with alarm symptoms:

• Upper GI endoscopy

MANAGEMENT OF DYSPEPSIA

1. NON-PHARMACOLOGICAL THERAPY

• Dietary modifications (bland diet)
• Avoid:
• Alcohol
• Smoking
• Caffeine
• Fatty foods
• Weight reduction
• Stress management

2. PHARMACOLOGICAL THERAPY

A. ANTACIDS

·        Example: Aluminum + Magnesium salts

·        Mechanism:

• Neutralize gastric acid
• Provide mucosal protection

·        Dose:

• 15 mL, 3–4 times daily

·        Note:

• Suspensions are more effective than tablets

B. H2 RECEPTOR ANTAGONISTS

·        Drugs:

• Ranitidine
• Famotidine

·        Mechanism:

• Block histamine (H2 receptors) → ↓ acid secretion

·        Dose:

• Famotidine: 20 mg BID or 40 mg OD
• Ranitidine: 150 mg BID or 300 mg OD

C. PROTON PUMP INHIBITORS (PPIs)

·        Drugs:

• Omeprazole 20 mg OD
• Rabeprazole 20 mg OD
• Lansoprazole 30 mg OD
• Pantoprazole 40 mg OD

·        Mechanism:

• Irreversibly inhibit H⁺/K⁺ ATPase (proton pump)

·        Key Point:

• Take 30–60 minutes before meals

D. MUCOSAL PROTECTIVE AGENT

Sucralfate

·        Mechanism:

• Forms protective barrier over ulcer
• Protects against acid, pepsin, bile

·        Dose:

• 1 g QID or 2 g BID

E. PROKINETIC AGENTS

Metoclopramide

·        Dose:

• 5–10 mg, three times daily

·        Mechanism:

• Dopamine (D2) receptor blockade
• ↑ Acetylcholine → ↑ gastric motility

·        Caution:

• Can cause neuropsychiatric side effects
• Use only under medical supervision

F. H. PYLORI ERADICATION

• Indicated if infection present
• Improves long-term symptoms

3. ALTERNATIVE THERAPIES

• Herbal options:
• Peppermint
• Caraway oil

SUMMARY (FOR QUICK REVISION)

• Dyspepsia = Upper abdominal discomfort
• Causes: Drugs, lifestyle, GERD, ulcers, H. pylori
• First step: Lifestyle modification
• Drugs:
• Antacids → Immediate relief
• H2 blockers → Moderate effect
• PPIs → Most effective
• Alarm symptoms → Endoscopy required

 

FAMILY PLANNING – ROLE OF PHARMACIST

1. Introduction

• Pharmacists play an important role in family planning services, especially in developing countries.
• Many people prefer pharmacies over clinics due to easy access, privacy, and quick service.
• Pharmacies serve a large number of family planning users who may not visit hospitals or doctors.

2. Advantages of Pharmacies in Family Planning

1) Convenience

• Easily accessible in urban and rural areas
• Less waiting time compared to hospitals
• Usually well-stocked with contraceptives
• Located near homes → reduces travel time and cost
• Customers can buy other household items along with medicines

2) Choice of Products

Pharmacies provide a wide range of contraceptives:

• Condoms
• Oral contraceptive pills (OCPs)
• Spermicidal jellies, creams, tablets
• Intrauterine devices (IUDs) (in some settings)
• Injectable contraceptives

3) Choice of Provider

Customers prefer pharmacies based on:

• Location (near home/clinic)
• Trust and familiarity with pharmacist
• Gender preference (female clients may prefer female staff)

Additional factors:

• Social contact: Pharmacist may be a known person
• Confidentiality & anonymity: No need to share personal details
• Privacy: Encourages discussion about contraception

4) Free Information and Advice

• Pharmacists provide free counseling in simple language
• Often first point of contact for health advice, especially for poor/uneducated populations
• Allows better patient control and interaction

3. Disadvantages of Pharmacies

• Higher cost of contraceptives compared to free government supply
• Lack of adequate knowledge among some pharmacists

4. Improving Pharmacist Knowledge

• In-service training programs
• Educational materials (brochures, posters)
• Social marketing programs
• Updating pharmacy curriculum
• Training improves:
• Knowledge
• Counseling skills
• Contraceptive use and sales

5. Sources of Knowledge for Pharmacists

1. Pharmacy education (limited training in family planning)
2. Pharmaceutical company representatives (product-specific knowledge)
3. In-service training programs (most important for comprehensive knowledge)

6. Role of Pharmacist in Promoting Family Planning

A. Service & Supply

• Maintain adequate stock of contraceptives
• Provide variety of methods and brands

B. Education & Counseling

• Give accurate and clear advice
• Encourage:
• New users to adopt contraception
• Existing users to continue or switch methods
• Use simple language for better understanding

C. Training & Skill Development

• Attend and promote training programs
• Improve communication and counseling skills

D. Awareness & Promotion

• Display:
• Posters
• Brochures
• Set up self-service displays for condoms, OCPs, spermicides
• Promote social marketing programs

E. Collaboration

• Work with:
• Family planning clinics
• Doctors and healthcare professionals
• Pharmacist organizations

F. Policy & Advocacy

• Support policies allowing:
• Easy access to contraceptives
• Promote family planning through:
• Media
• Public awareness

G. Referral Role

• Refer patients to doctors when necessary:
• Diabetic women
• Hypertensive women
• High-risk cases before giving oral contraceptives

7. Key Points for Exams

• Pharmacists are accessible and trusted providers
• Provide products + counseling + privacy
• Major strengths: Convenience, Choice, Confidentiality, Free advice
• Main limitation: Knowledge gap (can be improved by training)

 

---

TREATMENT AND PREVENTION OF DEFICIENCY DISORDERS

INTRODUCTION

• Micronutrients (vitamins and minerals) are required in small amounts for:

  • Growth and development
  • Maintenance of health
  • Disease prevention

• Some nutrients are not synthesized in the body, so they must be obtained from diet.

• Nutritional deficiency occurs when:

  • Intake is inadequate
  • Absorption is impaired
  • Requirements are increased

• Common causes:

  • Poor diet
  • Disease conditions
  • Malabsorption
  • Drug interference

---

GENERAL SYMPTOMS OF DEFICIENCY

• Pallor (pale skin)
• Fatigue and weakness
• Breathlessness
• Palpitations
• Dizziness or fainting
• Depression
• Tingling and numbness
• Hair loss
• Poor concentration
• Menstrual irregularities
• Constipation
• Sleep disturbances

---

1. PROTEIN DEFICIENCY DISORDERS

Protein-Energy Malnutrition (PEM)

Common in children (1–3 years), leading to:

• Growth retardation
• Increased morbidity and mortality

Causes:

• Inadequate diet (poverty, ignorance)
• Infections and parasitic diseases

---

A. KWASHIORKOR

• Caused by protein deficiency with adequate calories

Clinical Features:

• Edema (especially feet)
• Distended abdomen
• Fatty liver
• Dermatitis and skin depigmentation
• Hair thinning
• Irritability, anorexia

Management:

• Gradual protein supplementation
• Balanced diet
• Treat infections

---

B. MARASMUS

• Severe deficiency of protein + calories

Clinical Features:

• Severe wasting (emaciation)
• Loss of fat and muscle
• Loose skin folds
• Dry skin
• Irritability, hunger

Management:

• Gradual nutritional rehabilitation
• Treat dehydration, infections
• Correct electrolyte imbalance

---

C. CACHEXIA

• Wasting syndrome due to chronic diseases (e.g., cancer, AIDS)

Features:

• Weight loss
• Muscle atrophy
• Weakness
• Loss of appetite

Treatment:

• Nutritional support
• Appetite stimulants (e.g., corticosteroids)
• Treat underlying disease

---

2. VITAMIN DEFICIENCY DISORDERS

Classification

• Fat-soluble: A, D, E, K
• Water-soluble: B-complex, C

---

A. VITAMIN A DEFICIENCY

Functions:

• Vision
• Immunity
• Growth and development

Deficiency:

• Night blindness
• Xerophthalmia
• Keratomalacia
• Blindness

Management:

• Vitamin A-rich foods (carrot, spinach, liver)
• Supplementation

---

B. VITAMIN D DEFICIENCY

Functions:

• Calcium & phosphorus regulation
• Bone health

Deficiency:

• Rickets (children)
• Osteomalacia (adults)

Sources:

• Sunlight
• Fish, egg yolk, fortified milk

Management:

• Sun exposure
• Vitamin D supplementation

---

C. VITAMIN E DEFICIENCY

Functions:

• Antioxidant
• Protects cell membranes

Deficiency:

• Neuropathy
• Myopathy
• Hemolysis

Management:

• Dietary intake (nuts, oils, green vegetables)
• Supplements if needed

---

D. VITAMIN K DEFICIENCY

Function:

• Blood clotting

Deficiency:

• Bleeding disorders
• Easy bruising

Management:

• Green leafy vegetables
• Supplementation

---

E. VITAMIN B-COMPLEX DEFICIENCY

Includes:

• B1 (Thiamine) → Beriberi
• B2 (Riboflavin) → Cheilosis, glossitis
• B3 (Niacin) → Pellagra
• B9 (Folic acid) → Anemia, neural tube defects
• B12 → Megaloblastic anemia, neuropathy

Sources:

• Whole grains
• Meat, fish
• Legumes

Management:

• Balanced diet
• Supplementation

---

3. MINERAL DEFICIENCY DISORDERS

A. CALCIUM DEFICIENCY

• Causes: Poor intake, kidney disease
• Symptoms: Cramps, osteoporosis

B. IRON DEFICIENCY

• Leads to anemia
• Symptoms: Fatigue, weakness

C. MAGNESIUM DEFICIENCY

• Symptoms: Weakness, cramps, arrhythmias

D. POTASSIUM DEFICIENCY

• Causes: Vomiting, diuretics
• Symptoms: Muscle weakness, arrhythmia

E. ZINC DEFICIENCY

• Symptoms: Poor immunity, hair loss, delayed healing

---

TREATMENT OF DEFICIENCY DISORDERS

1. Dietary Modification

• Balanced diet with:
  • Fruits and vegetables
  • Whole grains
  • Proteins (meat, eggs, pulses)

2. Supplementation

• Vitamins and minerals
• Combination therapy (e.g., calcium + vitamin D)

3. Treatment of Underlying Cause

• Infections
• Malabsorption disorders
• Medication adjustment

4. Emergency Treatment

• IV fluids and nutrients
• Hospitalization in severe cases

---

MALNUTRITION

Types:

1. Undernutrition

   • Wasting, stunting, underweight

2. Overnutrition

   • Obesity

---

CAUSES

• Poverty and food insecurity
• Malabsorption disorders
• Alcoholism
• Mental illness
• Poor mobility

---

SYMPTOMS

• Weight loss
• Fatigue
• Poor immunity
• Delayed wound healing
• Growth retardation in children

---

TREATMENT OF MALNUTRITION

• High-calorie, high-protein diet
• Nutritional supplements
• Tube feeding (if needed)
• IV nutrition (severe cases)

---

PREVENTION

• Balanced diet including:

  • Fruits and vegetables
  • Cereals and grains
  • Milk and dairy
  • Protein sources

• Health education

• Food fortification

• Regular health checkups

---

AIDS

 

ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS)

INTRODUCTION

• AIDS is a chronic, life-threatening condition caused by the Human Immunodeficiency Virus (HIV).
• HIV damages the immune system, especially CD4+ T lymphocytes, reducing the body’s ability to fight infections.
• It is primarily a sexually transmitted infection (STI) but can also spread via blood and from mother to child.
• Without treatment, HIV progresses to AIDS over several years.
• No cure exists, but Antiretroviral Therapy (ART) can control the disease and prolong life.

SYMPTOMS

1. Primary Infection (Acute HIV)

Occurs 2–4 weeks after infection.

Symptoms:

• Fever
• Headache
• Muscle and joint pain
• Rash
• Sore throat
• Painful mouth ulcers
• Swollen lymph nodes

👉 High viral load → highly infectious stage

2. Clinical Latent Stage (Chronic HIV)

• Usually asymptomatic
• May last ~10 years without treatment (longer with ART)

Features:

• Persistent lymphadenopathy
• Virus remains active in lymphoid tissues

3. Symptomatic HIV Infection

Symptoms:

• Fever
• Fatigue
• Chronic diarrhea
• Weight loss
• Oral candidiasis (thrush)
• Herpes zoster (shingles)
• Persistent lymph node enlargement

4. AIDS (Advanced Stage)

Features:

• Severe immunosuppression (CD4 < 200 cells/mm³)
• Opportunistic infections & cancers

Symptoms:

• Night sweats
• Chronic diarrhea
• Persistent fever
• Severe weight loss
• Oral lesions
• Skin rashes

PATHOGENESIS

1.     Entry & Replication

• HIV enters bloodstream → rapid viral replication
• High viral load in early phase

2.     CD4+ T Cell Depletion

• Acute phase:
• Viral destruction + cytotoxic T cell killing
• Chronic phase:
• Immune activation + reduced T cell production

3.     Immune Response

• CD8+ T cells control viral load partially
• Antibodies formed but do not eliminate virus

4.     Mucosal Damage

• Massive loss of CD4 cells in intestinal mucosa
• Due to CCR5 receptors (entry point for HIV)

5.     Progression to AIDS

• Gradual CD4 decline → opportunistic infections

CAUSES & TRANSMISSION

Modes of Transmission:

1. Unprotected sexual contact (vaginal, anal, oral)
2. Blood transfusion (rare due to screening)
3. Sharing contaminated needles/syringes
4. Mother-to-child transmission
• During pregnancy
• Childbirth
• Breastfeeding

DIAGNOSIS

1. Screening Test

• ELISA (Enzyme-Linked Immunosorbent Assay)
• Detects HIV antibodies
• Highly sensitive

Limitations:

• False positives: pregnancy, viral infections, vaccination
• False negatives: early infection (window period)

2. Confirmatory Test

• Western Blot Test

3. Viral Load Tests

• Measure HIV RNA in blood
• Methods:
• PCR (Polymerase Chain Reaction)
• Branched DNA assay

4. CD4 Count

• Normal: 500–1600 cells/mm³
• AIDS: <200 cells/mm³

WHO CLINICAL STAGING

Stage I

• Asymptomatic
• No AIDS

Stage II

• Minor mucocutaneous infections
• Recurrent upper respiratory infections

Stage III

• Chronic diarrhea (>1 month)
• Severe bacterial infections
• Pulmonary tuberculosis

Stage IV (AIDS)

• Opportunistic infections:
• Cerebral toxoplasmosis
• Esophageal candidiasis
• Kaposi’s sarcoma

TREATMENT

Antiretroviral Therapy (ART)

• Combination therapy (HAART)
• Reduces viral load
• Improves CD4 count
• Prevents disease progression

Classes of Anti-HIV Drugs

1.     NRTIs (Nucleoside Reverse Transcriptase Inhibitors)

• Example: Zidovudine, Lamivudine, Tenofovir

2.     NNRTIs (Non-Nucleoside RT Inhibitors)

• Example: Efavirenz, Nevirapine

3.     Protease Inhibitors (PIs)

• Example: Ritonavir, Atazanavir

4.     Entry/Fusion Inhibitors

• Example: Enfuvirtide, Maraviroc

5.     Integrase Inhibitors

• Example: Raltegravir

PREVENTION

1. Safe Sex Practices

• Use condoms
• Limit multiple partners

2. Abstinence

• Most effective prevention

3. Safe Needle Use

• Avoid sharing needles
• Needle exchange programs

4. Blood Safety

• Screening of blood products

5. Healthcare Precautions

• Use PPE (gloves, masks, goggles)
• Proper handling of body fluids

6. Prevention of Mother-to-Child Transmission

• ART during pregnancy
• Safe delivery practices
• Avoid breastfeeding if advised

KEY POINTS FOR EXAMS

• HIV targets CD4+ T cells
• Acute phase = high infectivity
• AIDS defined by CD4 < 200 cells/mm³
• ELISA → screening, Western blot → confirmation
• ART = lifelong treatment
• No cure, but manageable disease

 

 

Leprosy

 

LEPROSY (HANSEN’S DISEASE)

INTRODUCTION

·        Leprosy is a chronic infectious disease caused by:

• Mycobacterium leprae
• Mycobacterium lepromatosis

·        It is a slowly progressive granulomatous disease affecting:

• Skin
• Peripheral nerves
• Mucous membranes

·        Incubation period: Months to 40 years

·        Commonly affects cooler parts of the body:

• Eyes
• Nose
• Earlobes
• Hands & feet
• Testes

·        Causes:

• Skin lesions
• Nerve damage
• Deformities

·        Transmission:

• Mainly human-to-human (respiratory droplets)
• Rarely from animals (e.g., armadillos)

·        Discovered by Gerhard Armauer Hansen in 1873

·        WHO reduced prevalence with multidrug therapy (MDT), but still a public health issue in some countries.

CLASSIFICATION OF LEPROSY

1. Paucibacillary (PB) / Tuberculoid

• Few lesions (1–5)
• Hypopigmented or erythematous patches
• Loss of sensation (anesthesia)
• Strong immune response

Nerves commonly affected:

• Great auricular nerve
• Ulnar nerve
• Median nerve
• Radial nerve
• Common peroneal nerve
• Posterior tibial nerve
• Sural nerve

2. Multibacillary (MB) / Lepromatous

·        Numerous lesions (>5)

·        Symmetrical distribution

·        Nodules, plaques

·        Thickened dermis

·        May involve:

• Eyes
• Nose
• Testes
• Bones

·        Features:

• Nasal congestion, epistaxis
• High bacterial load

3. Borderline (Dimorphous)

• Most common form
• Intermediate between PB and MB
• Multiple lesions
• Nerve involvement → weakness + sensory loss

PATHOGENESIS

·        Entry: Respiratory tract

·        Bacilli:

• Invade Schwann cells of nerves
• Also found in macrophages

·        Slow multiplication (12–14 days per division)

Immune response determines disease type:

• Strong cell-mediated immunity (CMI) → PB type
• Weak CMI → MB type

Leprosy reactions:

• Type 1 (reversal reaction)
• Type 2 (erythema nodosum leprosum)

SIGNS AND SYMPTOMS

Skin manifestations

• Hypopigmented or reddish patches
• Loss of sensation
• Dry, thickened skin
• Nodules
• Painless ulcers
• Loss of eyebrows/eyelashes

Nerve involvement

• Numbness
• Muscle weakness/paralysis
• Enlarged peripheral nerves
• Loss of sensation → unnoticed injuries

Mucosal involvement

• Stuffy nose
• Nosebleeds

Advanced disease

• Deformities (hands/feet)
• Shortening of fingers/toes
• Chronic ulcers
• Blindness
• Nose deformity

DIAGNOSIS

Clinical diagnosis

• Hypopigmented patch with sensory loss
• Thickened peripheral nerves

Laboratory tests

• Skin smear:
• Acid-fast bacilli (Ziehl–Neelsen stain)
• Skin biopsy

Additional tests:

• Lepromin test
• PCR
• Liver & kidney function tests
• Nerve biopsy

TREATMENT (WHO MDT)

Paucibacillary (PB)

• Rifampicin
• Dapsone
• Duration: 6–12 months

Multibacillary (MB)

• Rifampicin
• Dapsone
• Clofazimine
• Duration: 12 months or more

Single lesion (WHO recommendation)

• Single-dose therapy:
• Rifampicin + Ofloxacin + Minocycline

Other management

• Steroids → for inflammation & nerve damage
• Early treatment prevents disability

COMPLICATIONS

• Blindness / glaucoma
• Facial deformities
• Infertility (in males)
• Kidney damage
• Claw hand deformity
• Chronic ulcers
• Permanent nerve damage

PREVENTION

·        Early diagnosis and treatment

·        Contact tracing

·        Public awareness

·        Chemoprophylaxis:

• Single-dose rifampicin for close contacts

·        Vaccine:

• No specific vaccine
• BCG gives partial protection

PATHOPHYSIOLOGY (SUMMARY)

·        Spread via nasal droplets

·        Affects:

• Skin
• Peripheral nerves
• Upper respiratory mucosa
• Eyes
• Testes

·        Key mechanism:

• Nerve damage → sensory loss → deformities